The FIRST Trial included 62 patients all of whom met the criteria for IA therapy. Results showed that only 10 percent of patients experienced a restoration of blood flow in the affected brain vessel and only 20.7 percent of patients were functionally independent at 90 days after their stroke event.
When the results of this trial were compared to previous studies designed to assess the effectiveness of IA therapy utilizing devices, there were notable differences. Blood flow was restored in around 85 percent of patients treated with IA therapy as compared to 10 percent of the untreated patients in the FIRST Trial.
More Articles on Spine:
The CORE Institute’s Management Company Partners with MedSynergies
3 Spine Surgeons on the Use of Robotics in the Operating Room
The Hospital for Spinal Surgery is Renamed
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.